AGX · Argan, Inc

The thesis

Argan's gas-power construction earnings are strong, but its order book shrank in the latest quarter, so the case stays unproven until new awards appear in backlog. The shares closed at $341.04 on 27 October 2026, 57.2% below the 52-week high of $796.28 and down 41.1% over three months (split- and dividend-adjusted daily closes). The next quarterly backlog figure, due in early December, settles whether awards are replacing finished work.

Argan reported second-quarter fiscal 2027 revenue of $383.976 million and diluted earnings per share of $3.76 on 2 September 2026. Revenue rose 61.5% from a year earlier and gross margin was 19.3%. Backlog at 31 July 2026 was $2.518 billion, down from $2.929 billion at 31 January 2026 (Argan results release).

The market is arguing about the fiscal 2028 earnings peak, not current profit. JPMorgan maintained Overweight on 29 September 2026 and cut its target from $800 to $785, calling peak-earnings fears overblown. Piper Sandler initiated on 9 September 2026 with Underweight and a $273 target.

The narrative is maturing: the story is well known, and the debate has moved from backlog growth to whether the award cycle has peaked. The shares fell from a $365.81 close on 14 October 2026 to $341.04 on 27 October 2026, and the 14-day relative strength index, a momentum gauge on a 0-100 scale, stood at 21.6 on 27 October 2026. Company news and SEC filings show nothing new since the 9 September 2026 dividend 8-K, so the decline came without a company announcement.

Bullish and bearish views on Argan, Inc

The bull case on Argan, Inc (AGX), in brief: Earnings are well ahead of forecasts. The bear case: The order book fell.

Bull case

• Earnings are well ahead of forecasts. Second-quarter earnings per share of $3.76 compared with an estimate of $2.67, according to a 2 September 2026 summary on public.com. The 61.5% revenue growth is a filed number.
• Shareholder payouts are rising. The 9 September 2026 Form 8-K raised the quarterly dividend 40%, from $0.50 to $0.70 per share, payable 30 October 2026 to holders of record on 22 October 2026. A $200 million buyback authorization runs through 31 January 2030.
• Gas-turbine demand upstream is strong. GE Vernova reported on 22 July 2026 that gas power equipment backlog plus slot reservations rose from 100 gigawatts to 116 gigawatts, and it expects at least 125 gigawatts by year-end 2026.
• The price sits far below the top target. JPMorgan's $785 target, set 29 September 2026, is more than double the 27 October 2026 close.

Bear case

• The order book fell. Backlog was $2.518 billion at 31 July 2026 against $2.929 billion at 31 January 2026. A further decline at the next report would show awards are not replacing completed projects.
• An analyst argues the award cycle has peaked. Piper Sandler's 9 September 2026 initiation cited limits on available work crews, per The Fly. Its $273 target is below the 27 October 2026 close.
• Customer concentration magnifies project risk. The 10-K risk factors say top customers exceed 60% of revenue, so one delayed or cancelled project can move results.
• Momentum is negative. The shares are down 41.1% over three months and the close of $341.04 on 27 October 2026 sits just above the $340 invalidation level in the previous note.

Price setup

The last close was $341.04 on 27 October 2026, 57.2% below the 52-week high of $796.28. The 14-day relative strength index of 21.6 is a deeply oversold reading, which describes how sharp the recent decline was and gives no information about direction.

The previous note set a daily close below $340 as its invalidation level, and the shares are $1.04 above it. This note moves the level to a daily close below $320, a round level under the 27 October 2026 close. Analyst targets span a wide range: $273 at Piper Sandler and $785 at JPMorgan.

Crowding evidence is limited. Retail media attention appeared in early October (a 7 October 2026 Benzinga piece and a Jim Cramer headline), and no insider selling or share issuance is documented in the news reviewed. The dividend record date of 22 October 2026 has passed.

Catalysts, next 30 days

• ~3 December to 9 December 2026 (est.) — Argan third-quarter fiscal 2027 report. This falls outside the 30-day window but decides the case: the company has not confirmed the date, and the backlog figure shows whether the order book recovers from $2.518 billion.

Elapsed catalysts

• 28 October 2026 — GE Vernova third-quarter 2026 results, before market open. Turbine bookings at GE Vernova have historically preceded Argan awards by two to four quarters. (passed 9d ago)
• 30 October 2026 — Argan's $0.70 quarterly dividend is payable. It confirms the 40% increase announced 9 September 2026 is being paid. (passed 7d ago)

What would change the view

The case breaks if backlog at the next quarterly report is at or below $2.518 billion, which would show awards are not replacing completed work. It also breaks on a daily close below $320, a level under the 27 October 2026 close of $341.04. A hyperscaler cutting its data-center capital spending outlook would support Piper Sandler's peak-cycle argument.

The case improves if the next report shows backlog above $2.518 billion, or if Argan announces a large new engineering, procurement and construction award before then. Strong GE Vernova bookings on 28 October 2026 would support later Argan awards, given the historical two-to-four-quarter lag.

What it trades with

Argan trades with gas-turbine and power-construction demand tied to data-center buildouts. GE Vernova is the closest read-through, because its turbine orders have led Argan's awards by two to four quarters. Hyperscaler capital-spending commentary also moves the shares, and the sample of observed co-movements here is too small to quantify.